⌘K

Login Start Free

Home/Filings/4/0001209191-16-109307

4//SEC Filing

Cara Therapeutics, Inc. 4

Accession 0001209191-16-109307

$TVRDCIK 0001346830operating

View on SEC.gov Company Profile

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 8:22 PM ET

Size

10.5 KB

Accession

0001209191-16-109307

Insider Transaction Report

Form 4

Period: 2016-03-16

Cara Therapeutics, Inc.CARA

Chief Financial Officer

Transactions

Exercise/Conversion
Common Stock
2016-03-16$0.78/sh+8,000$6,240→ 36,000 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2016-03-16−8,000→ 0 total
Exercise: $0.78Exp: 2016-09-29→ Common Stock (8,000 underlying)
Exercise/Conversion
Common Stock
2016-03-16$0.85/sh+10,000$8,500→ 46,000 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2016-03-16−10,000→ 0 total
Exercise: $0.85Exp: 2021-09-08→ Common Stock (10,000 underlying)

Footnotes (1)

[F1]Immediately exercisable.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cara Therapeutics, Inc.

CIK 0001346830

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001346830

Filing Metadata

Form type: 4
Filed: Mar 16, 8:00 PM ET
Accepted: Mar 17, 8:22 PM ET
Size: 10.5 KB

View on SEC.gov